NCT05941520 2026-04-13
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
11 trialsNCT06184750 2026-04-13
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06195306 2026-04-13
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06902311 2026-03-30
H-ASSIST
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting
NCT06075953 2026-03-16
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT06961955 2025-12-09
FAST NOVEMBER
University of Utah
Phase 2 Recruiting
NCT06185205 2025-11-21
ASHBY
Virginia Commonwealth University
Phase 2 Recruiting
NCT04084730 2025-09-16
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03936478 2025-08-01
MAPBI
University of Wisconsin, Madison
Phase 2 Recruiting
NCT06677944 2024-11-07
Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
Yonsei University
Phase 2 Recruiting
NCT04666961 2022-04-22
HORNEO01
Institut Cancerologie de l'Ouest
Phase 2 Recruiting